Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 5Cholangiocarcinoma 4Colonic Neoplasms 3Gallbladder Neoplasms 2Fistula 2Esophageal Neoplasms 2Bile Duct Neoplasms 2Anastomotic Leak 2Stomach Neoplasms 1Rectal Neoplasms 1Obesity, Morbid 1Obesity 1Klatskin Tumor 1Duodenal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Bites and Stings 1

Interventions

Gemcitabine 40Cisplatin 24Capecitabine 21Fluorouracil 19Oxaliplatin 17Leucovorin 14pembrolizumab 9Irinotecan 8Radiotherapy 7Erlotinib Hydrochloride 7durvalumab 6Sorafenib 4Photochemotherapy 4Magnetic Resonance Spectroscopy 4Carboplatin 4trametinib 3Trastuzumab 3Radiofrequency Ablation 3Long-Term Synaptic Depression 3Interleukin-12 Subunit p35 3Filgrastim 3Drug Therapy 3Dihematoporphyrin Ether 3Dexamethasone 3Cholangiopancreatography, Endoscopic Retrograde 3Chemotherapy, Adjuvant 3trifluridine tipiracil drug combination 2tivozanib 2tislelizumab 2spartalizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × Stents × Gastrointestinal × Clear all
NCT06274879 2026-05-26

Ablatio

Insel Gruppe AG, University Hospital Bern

Phase 2 Recruiting
36 enrolled
Gastrointestinal

Bile Duct Neoplasms

NCT03763214 2018-12-04

PTFE Stents for Treatment of Malignant Biliary Strictures

Johann Wolfgang Goethe University Hospital

Phase NA Unknown
64 enrolled
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡